Assessment of the safety of Immunoglobulin and recombinant human hylaluronidase in the treatment of patients with primary immunodeficiency Assessment of the safety of Immunoglobulin and recombinant human hylaluronidase in the treatment of ...
Tolerability, Safety and Product Administration Evaluation of rHuPH20 Facilitated Subcutaneous Treatment with Immune Globulin (Human), 10% in Subjects with Primary Immunodeficiency Diseases – A Study in Europe - Tolerability and Safety of IG, 10% with rHuPH20 in PIDD Tolerability, Safety and Product Administration Evaluation of rHuPH20 Facilitated Subcutaneous Treat ...